Edition:
United States

Motif Bio PLC (MTFB.OQ)

MTFB.OQ on NASDAQ Stock Exchange Capital Market

9.25USD
15 Dec 2017
Change (% chg)

$-0.10 (-1.07%)
Prev Close
$9.35
Open
$9.05
Day's High
$9.25
Day's Low
$9.00
Volume
1,330
Avg. Vol
1,505
52-wk High
$13.70
52-wk Low
$5.36

Chart for

About

Motif Bio plc is a clinical-stage biopharmaceutical company. The Company is engaged in development of antibiotics, which are designed for treatment of infections caused by multi-drug resistant bacteria. It operates in the development and commercialization of pharmaceutical formulations segment. The Company is focused on... (more)

Overall

Beta: --
Market Cap(Mil.): £90.34
Shares Outstanding(Mil.): 263.52
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 198.20 16.04
EPS (TTM): -- -- --
ROI: -- -11.76 34.69
ROE: -- -36.72 15.46

BRIEF-Motif Bio Plc To Offer And Sell Up To 1.2 Mln ADR

* MOTIF BIO PLC FILES FOR OFFER AND SALE OF UP TO 1.2 MILLION AMERICAN DEPOSITARY SHARES - SEC FILING Source text for Eikon: (http://bit.ly/2CfPXz9) Further company coverage:

Dec 13 2017

BRIEF-Motif Bio secures up to US$20 million debt financing

* ‍Company has entered into an agreement for up to US$20 million in debt financing with Hercules Capital, Inc​

Nov 15 2017

Earnings vs. Estimates